Oral administration of the amino acids cystine and theanine attenuates the adverse events of S-1 adjuvant chemotherapy in gastrointestinal cancer patients

Takashi Tsuchiya, Hiroshi Honda, Masaya Oikawa, Tetsuya Kakita, Atsushi Oyama, Hidekazu Oishi, Katsuyuki Tochikubo, Takanao Hashimoto, Shigekazu Kurihara, Tetsuro Shibakusa, Takashi Kayahara

    研究成果: Contribution to journalArticle

    11 引用 (Scopus)

    抜粋

    Background: Nutritional therapy is used to reduce the adverse events (AEs) of anticancer drugs. Here, we determined whether the amino acids cystine and theanine, which provide substrates for glutathione, attenuated the AEs of S-1 adjuvant chemotherapy. Methods: Patients scheduled to receive S-1 adjuvant chemotherapy were randomized to the C/T or the control groups. The C/T group received 700 mg cystine and 280 mg theanine orally 1 week before the administration of S-1, which then continued for 5 weeks. Each group received S-1 for 4 weeks. Blood sampling was performed and AEs were evaluated (CTCAE ver. 4.0) before and after the administration of S-1. S-1 was discontinued when AEs ≥ grade 2 occurred. Results: The incidences of AEs of any grade and those over grade 2 were lower in the C/T group than in the controls. The incidence of diarrhea (G ≥ 2) was significantly less (p < 0.05) in the C/T group (3.1 %) than in the controls (25.8 %). The duration and completion rate of the S-1 adjuvant chemotherapy were significantly longer (p < 0.01) and higher (p < 0.01), respectively, in the C/T group (complete ratio: 75.0 %, duration: 24.8 ± 5.8 days) than in the controls (complete ratio: 35.5 %, duration: 20.0 ± 7.7 days). Conclusions: The oral administration of cystine and theanine attenuated the AEs of S-1 adjuvant chemotherapy and increased the S-1 completion rate, suggesting that cystine and theanine is a useful supportive care for chemotherapy.

    元の言語英語
    ページ(範囲)1085-1090
    ページ数6
    ジャーナルInternational Journal of Clinical Oncology
    21
    発行部数6
    DOI
    出版物ステータス出版済み - 12 1 2016

    All Science Journal Classification (ASJC) codes

    • Surgery
    • Hematology
    • Oncology

    フィンガープリント Oral administration of the amino acids cystine and theanine attenuates the adverse events of S-1 adjuvant chemotherapy in gastrointestinal cancer patients' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Tsuchiya, T., Honda, H., Oikawa, M., Kakita, T., Oyama, A., Oishi, H., Tochikubo, K., Hashimoto, T., Kurihara, S., Shibakusa, T., & Kayahara, T. (2016). Oral administration of the amino acids cystine and theanine attenuates the adverse events of S-1 adjuvant chemotherapy in gastrointestinal cancer patients. International Journal of Clinical Oncology, 21(6), 1085-1090. https://doi.org/10.1007/s10147-016-0996-7